AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22082672
Drug: Celivarone 50
RxNorm normalized name: Celivarone
DrugBank: Celivarone (DB16012)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celivarone 50 mg/d
Trial: 22082672
Drug: Celivarone 100
RxNorm normalized name: Celivarone
DrugBank: Celivarone (DB16012)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celivarone 100 mg/d
Trial: 22082672
Drug: Celivarone 300
RxNorm normalized name: Celivarone
DrugBank: Celivarone (DB16012)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celivarone 300 mg/d
Trial: 22082672
Drug: Amiodarone 200
RxNorm normalized name: amiodarone 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone 200 mg/d (after loading dose of 600 mg/d for 10 days)
Trial: 19408831
Drug: Enoxaparin 1
RxNorm normalized name: ENOXAPARIN 100MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 1 mg/kg body weight s.c. twice daily
Trial: 19408831
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (Heparin - 'Biochemie' 25.000 IU/5 ml)
Trial: 11318080
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg once daily, titrated to 20 mg once daily and then 40 mg once daily as needed.
Trial: 11318080
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg once daily, titrated to 40 mg once daily and then 40 mg twice daily as needed.
Trial: 3311275
Drug: Ciprofloxacin 250
RxNorm normalized name: ciprofloxacin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 250 mg twice daily for 3 days as prophylaxis
Trial: 27943311
Drug: FV-100 200
RxNorm normalized name: HORSERADISH 10 g in 100 mL TOPICAL LIQUID [NWK A-FV]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FV-100 200 mg QD
Trial: 27943311
Drug: FV-100 400
RxNorm normalized name: HORSERADISH 10 g in 100 mL TOPICAL LIQUID [NWK A-FV]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FV-100 400 mg QD
Trial: 27943311
Drug: Valacyclovir 1000
RxNorm normalized name: valacyclovir 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 1000 mg TID
Trial: 22554294
Drug: MHA (microparticle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHA (microparticle size) coated non-etched implants (G1)
Trial: 22554294
Drug: NHA (nanoparticle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NHA (nanoparticle size) coated non-etched implants (G2)
Trial: 22554294
Drug: MHA mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHA mixed with whole human blood without surface treatment (G5)
Trial: 22554294
Drug: NHA mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NHA mixed with whole human blood without surface treatment (G6)
Trial: 21216835
Drug: Tacrolimus and
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus and mycophenolate mofetil therapy (COMBO)
Trial: 18053320
Drug: Exenatide 5
RxNorm normalized name: EXENATIDE 5MCG/DOSE 1.2ML 60D PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide 5 µg BID for 30 weeks, then 5 µg BID for 4 weeks, then 10 µg BID for ≥ 3 years
Trial: 12571543
Drug: Nurse-monitored structured
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-monitored structured care program with uptitration of enalapril to a target dose of 10 mg twice a day
Trial: 1458072
Drug: Amphotericin in
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin in fat emulsion (2 g/l fat emulsion)
Trial: 15123861
Drug: Phenobarbitone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbitone (5 mg/kg/day for 3 days)
Trial: 9566630
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia (TIVA) based on propofol and alfentanil
Trial: 9471197
Drug: Thymostimulin +
RxNorm normalized name: thymostimulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymostimulin + concurrent hyperfractionated carboplatin and irradiation
Trial: 9471197
Drug: Concurrent hyperfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent hyperfractionated carboplatin and irradiation
Trial: 1826920
Drug: Back school
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Back school therapy
Trial: 7074980
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg naloxone administered to women on days 2‐4 of the puerperium
Trial: 29895376
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of elemental calcium as calcium citrate
Trial: 24793078
Drug: ABH Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABH Gel (lorazepam, diphenhydramine, haloperidol)
Trial: 24793078
Drug: ABH Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABH Gel
Trial: 24793078
Drug: ABH Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABH Gel and Placebo
Trial: 20881623
Drug: Physical examinations
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical examinations by an occupational medicine physician
Trial: 18574656
Drug: CFPN-PI for
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CFPN-PI for 5 days (9-10 mg/kg/day, three times a day)
Trial: 15830233
Drug: Delta(9)-THC 10
RxNorm normalized name: .DELTA.1-THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delta(9)-THC 10 mg
Trial: 15830233
Drug: Delta(9)-THC 20
RxNorm normalized name: .DELTA.1-THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delta(9)-THC 20 mg
Trial: 15830233
Drug: Delta(9)-THC (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delta(9)-THC (10 and 20 mg)
Trial: 9548151
Drug: FSH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSH treatment (60 patients)
Trial: 9548151
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (30 patients)
Trial: 9548151
Drug: FSH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSH treatment
Trial: 2963532
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g vitamin E/d
Trial: 24401815
Drug: 0.45 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Trial: 24401815
Drug: 0.9 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Trial: 24401815
Drug: 1.8 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g/d eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Trial: 9679843
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (100 microg twice daily)
Trial: 15696076
Drug: Montelukast (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (5-10 mg nightly depending on age)
Trial: 14521805
Drug: Weekly doses
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly doses of cisplatin
Trial: 14521805
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 5‐fluorouracil and cisplatin
Trial: 10231100
Drug: Ketoprofen 200
RxNorm normalized name: ketoprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 200 mg once daily for 6 weeks
Trial: 8542158
Drug: Inhaled glucocorticoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled glucocorticoid (budesonide 800 micrograms twice daily for 3 weeks)
Trial: 1468295
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro skills test for insulin preparation
Trial: 6398781
Drug: Urokinase: 800,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urokinase: 800,000 CTA units/day for three days followed by oral anticoagulants
Trial: 6398781
Drug: Heparin: mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin: mean daily dose 30,000 units for seven days followed by oral anticoagulants
Trial: 6398781
Drug: Urokinase: 3,300,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urokinase: 3,300,000 CTA units in 12 hours followed by oral anticoagulants
Trial: 17265529
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dl alpha‐tocopheryl acetate
Trial: 17265529
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg beta‐carotene
Trial: 12803676
Drug: Statins (HMG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins (HMG CoA inhibitors)
Trial: 2339202
Drug: ONO‐3708 (thromboxane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐3708 (thromboxane A2 antagonist) administered at a dose of 2 micrograms/kg/min
Trial: 28779930
Drug: Whole body
RxNorm normalized name: MaxiVision Whole Body Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole body vibration therapy (WBV) combined with 6 different types of exercises at 30 hz frequency, 2 mm amplitude for 4 weeks
Trial: 21722098
Drug: High-volume (26
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-volume (26 ml) ropivacaine 1% with epinephrine
Trial: 16385193
Drug: Real-life practice
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real-life practice studies (e.g., Triumph project, Quadraet study, ALF-ONE study)
Trial: 15244498
Drug: Aciclovir 800
RxNorm normalized name: Aciclovir 800 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aciclovir 800 mg + MMF 1 g
Trial: 15244498
Drug: Valaciclovir 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 2 g + MMF 1 g
Trial: 15244498
Drug: Valaciclovir 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 2 g alone
Trial: 15244498
Drug: Aciclovir 800
RxNorm normalized name: Aciclovir 800 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aciclovir 800 mg alone
Trial: 15244498
Drug: MMF 1
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF 1 g alone
Trial: 9251949
Drug: Ampicillin/sulbactam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin/sulbactam (1 g ampicillin plus 0.5 g sulbactam)
Trial: 9251949
Drug: Cefotetan (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotetan (1 g cefotetan)
Trial: 8489308
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment in randomized trial
Trial: 8489308
Drug: Non-operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative treatment in randomized trial
Trial: 27296661
Drug: Innovative combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Innovative combination of formal and peer education followed by FibroScan
Trial: 24914779
Drug: Pregabalin 75
RxNorm normalized name: pregabalin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 75 mg twice daily for 5 days
Trial: 18390085
Drug: Dinoprostone vaginal
RxNorm normalized name: dinoprostone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone vaginal insert (10 mg) administered for 12 hours without oxytocin (group I)
Trial: 18390085
Drug: Dinoprostone vaginal
RxNorm normalized name: dinoprostone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone vaginal insert (10 mg) with oxytocin (group II)
Trial: 15012730
Drug: 1‐deamino‐8‐D‐arginine vasopressin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1‐deamino‐8‐D‐arginine vasopressin (dDAVP) administration
Trial: 11023260
Drug: Mandibular implant‐supported
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular implant‐supported overdentures
Trial: 8993091
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of sertraline to ongoing treatment
Trial: 8993091
Drug: Clomipramine dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine dose increase
Trial: 30834850
Drug: Table (nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Table (nutrition table with information on energy and main nutrients per 100 g)
Trial: 30096878
Drug: 600 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 g/day blackberries (BB, 1500 mg/day flavonoids)
Trial: 30096878
Drug: Calorie and
RxNorm normalized name: TwoCal HN Calorie and Protein Dense Nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calorie and carbohydrate matched amount of gelatin (GEL, flavonoid-free control)
Trial: 21887804
Drug: Fufang Danshen
RxNorm normalized name: DANSHEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fufang Danshen capsule 1000 mg twice-daily
Trial: 19020291
Drug: Caffeine (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (9 mg/kg)
Trial: 19020291
Drug: Quercetin (2,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin (2,000 mg)
Trial: 14756855
Drug: Rofecoxib 25
RxNorm normalized name: rofecoxib 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 25 mg or 50 mg daily for 10 days, starting 5 days before menstrual flow.
Trial: 9990415
Drug: Tretinoin 0.1%
RxNorm normalized name: TRETINOIN 0.1% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.1% cream
Trial: 9990419
Drug: Tretinoin 0.01%
RxNorm normalized name: TRETINOIN 0.01% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.01% gel
Trial: 9990419
Drug: Tretinoin 0.1%
RxNorm normalized name: TRETINOIN 0.1% CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin 0.1% gel microsphere
Trial: 8071051
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg I/mL iopromide
Trial: 8071051
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg I/mL ioversol
Trial: 8071051
Drug: 128 mg
RxNorm normalized name: citric acid 128 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 128 mg I/mL iopamidol
Trial: 22999066
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (30 g alcohol/d)
Trial: 16291444
Drug: Using the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Using the correction factor with 500 mg/dL of p‐Hgb
Trial: 12077012
Drug: Post-exercise (31)P‐MRS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-exercise (31)P‐MRS indices of muscle oxidative metabolism in DM and PM patients
Trial: 10780258
Drug: Dexamethasone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (2 mg)
Trial: 10780258
Drug: Cocaine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (12 mg and 50 mg)
Trial: 10780258
Drug: Dexamethasone (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0 mg)
Trial: 2240382
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (1.8 g eicosapentaenoic acid and 1.2 g docosahexaenoic acid)
Trial: 2240382
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (3 g linoleic acid)
Trial: 337220
Drug: Hypnotic analgesia
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic analgesia procedure
Trial: 23135605
Drug: Salvinorin A
RxNorm normalized name: Salvinorin A
DrugBank: Salvinorin A (DB12327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvinorin A (0.375-21 μg/kg)
Trial: 11743506
Drug: Dornase alfa
RxNorm normalized name: Dornase Alfa
DrugBank: Dornase alfa (DB00003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dornase alfa 2.5 mg once daily
Trial: 9565416
Drug: L-thyroxine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine (8 microg/kg birth weight per day)
Trial: 8168332
Drug: Intravenous ouabain
RxNorm normalized name: ouabain
DrugBank: Ouabain (DB01092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ouabain
Trial: 2908528
Drug: KC8702 (new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KC8702 (new method vaccine)
Trial: 2908528
Drug: 21A (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21A (conventional vaccine)
Trial: 29231610
Drug: Fire needling
RxNorm normalized name: Fire Out
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fire needling therapy applied after ovulation and at the end of the premenstrual stage.
Trial: 29231610
Drug: Regular sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular sequential therapy of acupuncture (control group).
Trial: 25262192
Drug: Oral gabapentin
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral gabapentin and intradermal injection of lidocaine
Trial: 23008027
Drug: Acridine orange
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acridine orange therapy
Trial: 17138198
Drug: Fentanyl iontophoretic
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl iontophoretic transdermal system (40 mug fentanyl, 10-minute infusion/lockout, up to 6 doses/h)
Trial: 17138198
Drug: Morphine intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine intravenous patient-controlled analgesia (1-mg morphine bolus, 5-minute lockout, up to 10 mg/h)
Trial: 17138198
Drug: Fentanyl iontophoretic
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl iontophoretic transdermal system
Trial: 20186064
Drug: Morphine intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine intravenous patient-controlled analgesia
Trial: 10703677
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron dextran (ivID) protocol, 100 mg loading doses for 2 weeks followed by 25 to 150 mg weekly for 6 months, targeting TSAT between 30 and 50%.
Trial: 10703677
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving ivID doses of 25 to 150 mg/week for 6 months, targeting TSAT of 20 to 30%.
Trial: 3890032
Drug: Combined chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined chemotherapy using vincristine, dactinomycin, adriamycin, cyclophosphamide until maximum tumor reduction, followed by radiotherapy or surgery on the residual mass only
Trial: 9140153
Drug: Omeprazole (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (80 mg as bolus, followed by 8 mg/h for 72 hours, plus 20 mg orally from day 3 until follow-up on day 21)
Trial: 8430920
Drug: Cetirizine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 40 mg
Trial: 21891871
Drug: Discontinued galantamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinued galantamine treatment
Trial: 17932613
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (trans-sacral magnetic stimulation)
Trial: 16626573
Drug: Intracoronary injection
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary injection of autologous mesenchymal stem cells (n = 12)
Trial: 8247887
Drug: Experimental approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental approach to preparation for surgery; details on dosage and duration not available.
Trial: 30129666
Drug: Hydrocortisone 200
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone 200 mg
Trial: 18374840
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (thrice daily)
Trial: 14571829
Drug: OCM-O group
RxNorm normalized name: Padimate O
DrugBank: Padimate O (DB11570)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OCM-O group (omeprazole 20 mg once daily)
Trial: 14571829
Drug: OCM group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OCM group (without acid suppressing agents)
Trial: 10774106
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 1 g of Dipyrone
Trial: 2866338
Drug: Stilboestrol 5
RxNorm normalized name: Stilboestrol
DrugBank: Diethylstilbestrol (DB00255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stilboestrol 5 mg daily
Trial: 24534170
Drug: gelled pectin
RxNorm normalized name: Pectin
DrugBank: Pectin (DB11158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gelled pectin (10 g)
Trial: 24534170
Drug: viscous pectin
RxNorm normalized name: Pectin
DrugBank: Pectin (DB11158)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: viscous pectin (10 g)
Trial: 24534170
Drug: capsules
RxNorm normalized name: VG capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: capsules